SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950168-01-000215
Filing Date
2001-02-12
Accepted
2001-02-12 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G-FREDRIC N. ESHELMAN 0001.txt SC 13G 3051
  Complete submission text file 0000950168-01-000215.txt   4980
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Subject) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48083 | Film No.: 1533216
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address PPD INC 3151 17TH STREET EXTENSION WILMINGTON NC 28412
Business Address PPD INC 3151 17TH STREET EXTENSION WILMINGTON NC 28412 9102510081
ESHELMAN FREDRIC N (Filed by) CIK: 0001033409 (see all company filings)